PPIs increase risk of SBP in hospitalized cirrhotics

By  |  April 20, 2012 | 

In this case-control study from a single institution of patients hospitalized with cirrhosis, those that developed SBP were almost twice as likely to have received a PPI in the previous 7 days (71% versus 42%), and those who had not taken a PPI in the past 90 days had a 70% lower odds of developing SBP compared to those that had received a PPI within the last 7 days. Although retrospective, this study should cause us to pause and consider the risks of starting or maintaining PPI therapy in patients hospitalized with cirrhosis (abstract)

Leave A Comment

About the Author:

Danielle Scheurer
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Categories

Related Posts

By  | June 29, 2013 |  0
This large systematic review found rectal NSAIDs significantly reduced the risk of post-ERCP pancreatitis compared to pancreatic duct stents (abstract).
By  | June 22, 2013 |  0
This large population-based cohort found the most common causes of drug induced liver injury to be augmentin and diclofenac, followed by herbal and nutritional supplements (abstract).
By  | May 25, 2013 |  0
This large trial of patients with a relative contraindication for enteral feeds were randomized to early TPN or usual care. There were no differences in the groups in 60 day mortality or LOS, but those on TPN did have a shorter time ventilated and less muscle/fat loss. It is unclear based on this trial if […]